4//SEC Filing
Wilson Jason Douglas 4
Accession 0001209191-19-053686
CIK 0001358762other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 3:39 PM ET
Size
13.6 KB
Accession
0001209191-19-053686
Insider Transaction Report
Form 4
Wilson Jason Douglas
See Remarks
Transactions
- Conversion
Class A common stock
2019-10-17+10,000→ 17,350 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-10-17−10,000→ 44,881 totalExercise: $11.00Exp: 2026-05-25→ Class B common stock (10,000 underlying) - Conversion
Class B common stock
2019-10-17−10,000→ 18,827 total→ Class A common stock (10,000 underlying) - Sale
Class A common stock
2019-10-17$170.00/sh−10,000$1,700,000→ 7,350 total - Exercise/Conversion
Class B common stock
2019-10-17$11.00/sh+10,000$110,000→ 28,827 total→ Class A common stock (10,000 underlying)
Footnotes (3)
- [F1]The exercise, conversion, and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2018.
- [F2]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F3]The options, representing a right to purchase a total of 101,881 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016, subject to continued service through each vesting date.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001662395
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 3:39 PM ET
- Size
- 13.6 KB